Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bin Gan

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Advanced Materials (Deerfield Beach, Fla.)|August 13, 2024
Machine Learning-Enabled Tomographic Imaging of Chemical Short-Range Atomic OrderingYue Li, Timoteo Colnaghi, Yilun Gong, et al.
Ebiomedicine|April 28, 2019
Analysis of resistance mechanisms to abivertinib, a third-generation EGFR tyrosine kinase inhibitor, in patients with EGFR T790M-positive non-small cell lung cancer from a phase I trialYi-Chen Zhang, Zhi-Hong Chen, Xu-Chao Zhang, et al.
Science Bulletin|January 7, 2024
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trialSi-Yang Maggie Liu, Jie Huang, Jia-Yi Deng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2021
A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non-Small Cell Lung Cancer: a Multicenter Phase I/II StudyQing Zhou, Lin Wu, Pei Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2017
Acquired <i>MET</i> Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non-Small Cell Lung CancerAnna Li, Jin-Ji Yang, Xu-Chao Zhang, et al.
Pediatrics and Neonatology|April 27, 2023
Effect of birth asphyxia on neonatal blood glucose during the early postnatal life: A multi-center study in Hubei Province, ChinaChun-Hua Liu, Hong-Yan Liu, Si-Cong Peng, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Advanced Materials (Deerfield Beach, Fla.)|August 13, 2024
Machine Learning-Enabled Tomographic Imaging of Chemical Short-Range Atomic OrderingYue Li, Timoteo Colnaghi, Yilun Gong, et al.
Ebiomedicine|April 28, 2019
Analysis of resistance mechanisms to abivertinib, a third-generation EGFR tyrosine kinase inhibitor, in patients with EGFR T790M-positive non-small cell lung cancer from a phase I trialYi-Chen Zhang, Zhi-Hong Chen, Xu-Chao Zhang, et al.
Science Bulletin|January 7, 2024
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trialSi-Yang Maggie Liu, Jie Huang, Jia-Yi Deng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2021
A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non-Small Cell Lung Cancer: a Multicenter Phase I/II StudyQing Zhou, Lin Wu, Pei Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2017
Acquired <i>MET</i> Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non-Small Cell Lung CancerAnna Li, Jin-Ji Yang, Xu-Chao Zhang, et al.
Pediatrics and Neonatology|April 27, 2023
Effect of birth asphyxia on neonatal blood glucose during the early postnatal life: A multi-center study in Hubei Province, ChinaChun-Hua Liu, Hong-Yan Liu, Si-Cong Peng, et al.
Pageof 4